 TNF inhibitors are commonly the first drug prescribed when a patient begins biologic therapy.They have the most extensive history of clinical evidence because they have been available the longest, are the most accessible, and are often the least expensive.Initially, it was thought that TNF inhibitors inactivate the proinflammatory cytokine by direct neutralization, but TNF signaling is a very complex process.